Nu Wave Investment Management, LLC Dexcom Inc Transaction History

Nu Wave Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	BUY	$67.99 - $132.89 $370,069 - $723,320	5,443 New	5,443 $406,000
Q1 2022 Apr 12, 2022	SELL	$94.08 - $130.2 $167,462 - $231,755	-1,780 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$129.87 - $162.82 $231,168 - $289,819	1,780 New	1,780 $956,000
Q2 2021 Jul 16, 2021	SELL	$80.99 - $107.93 $4,697 - $6,259	-58 Closed	0 $0
Q1 2021 Apr 09, 2021	SELL	$84.79 - $104.74 $678 - $837	-8 Reduced 12.12%	58 $21,000
Q4 2020 Jan 11, 2021	SELL	$78.0 - $104.5 $32,292 - $43,263	-414 Reduced 86.25%	66 $24,000
Q3 2020 Oct 23, 2020	SELL	$95.51 - $112.95 $327,790 - $387,644	-3,432 Reduced 87.73%	480 $198,000
Q2 2020 Jul 13, 2020	BUY	$62.68 - $105.34 $245,204 - $412,090	3,912 New	3,912 $1.47 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nu Wave Investment Management, LLC with notifications on news.